CDCA2 is a diagnostic and prognostic marker for liver cancer[36,37] and promotes hepatocellular carcinoma development via the AKT-mTOR pathway.[38] In this study, CDCA2 was overexpressed in LUAD tissues. Here, MTOR is linked to hepatocellular carcinoma.